ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News

Ritter sells to US life science company Avantor for 890 million euros

Photo: Dr. Jochen Tyrolt, Part­ner at GLEISS LUTZ in Stuttgart
16. April 2021

Schwab­mün­chen — A Gleiss Lutz team has advi­sed the family-owned Ritter Group on the sale of the company to US tech­no­logy group Avan­tor. The purchase price is appro­xi­m­ately €890 million, subject to further payments depen­ding on the achie­ve­ment of certain perfor­­mance-based mile­sto­nes. The tran­sac­tion is expec­ted to close in the 3rd quar­ter of 2021.

Ritter is head­quar­te­red in Schwab­mün­chen, Germany, and is one of the fastest growing manu­fac­tu­r­ers of high-quality consu­ma­bles for liquid hand­ling, auto­ma­ted analy­sis and clini­cal test­ing, inclu­ding conduc­tive pipette tips. These consu­ma­bles are central to a variety of mole­cu­lar scree­ning and diagno­stic appli­ca­ti­ons, inclu­ding real-time poly­me­rase chain reac­tion (PCR), or as part of drug deve­lo­p­ment and clini­cal trials for phar­maceu­ti­cal and
Biotech­no­logy Research.

Avan­tor is a New York Stock Exch­ange-listed global leader in products and services used in key rese­arch, deve­lo­p­ment and manu­fac­tu­ring acti­vi­ties by custo­mers in the high-tech­­no­­logy, biotech­no­logy, health­care and public sectors. Globally, the company serves 225,000 custo­mer sites and works with rese­arch labo­ra­to­ries and scien­tists in more than 180 countries.

Advi­sor Ritter: Gleiss Lutz
Dr. Jochen Tyrolt (Part­ner, Stutt­gart), Dr. Chris­tian Cascante (Part­ner, Frank­furt, both Lead), Johan­nes Schrägle (Coun­sel, Stutt­gart), Dr. Patrick Moss­ler (Part­ner), Dr. Daniel Heck (Coun­sel, both Hamburg), Florian Schorn (Munich), Dr. Lucas Hert­neck, Nikolas
Frey (both Stutt­gart, all M&A), Dr. Dirk Wasmann (Part­ner, Stutt­gart), Dr. Thors­ten Gayk (Coun­sel, Hamburg, both Corpo­rate), Dr. Johann Wagner (Part­ner), Dr. Thomas Büche­ler (both Tax, Hamburg), Dr. Doris-Maria Schus­ter (Part­ner), Dr. Daniela Mayr (both Hamburg), Prof. Dr. Martin Diller (Part­ner), Dr. Sebas­tian Ernst (both Stutt­gart, all Labor Law), Dr. Alex­an­der Molle (Part­ner), Dr. Matthias Schilde, Jan Hinrichs (all IP/IT), Dr. Chris­tian Hamann (Part­ner), Simon Wegmann (both Data Protec­tion Law), Dr. Enno Burk (Coun­sel), Dr. Chris­tina Fröb
(both Health­care, all Berlin), Dr. Jacob von Andreae (Part­ner), Aylin Hoffs (both Foreign Trade Law, both Düssel­dorf), Dr. Moritz Holm-Hadulla (Part­ner), Dr. Andreas Schüs­sel (both Anti­trust), Dr. Simon Wagner (Coun­sel, Dispute Reso­lu­tion, all Stutt­gart), Frank Schlo­b­ach (Part­ner), Dr. Thomas Kulzer (Coun­sel, both Finance), Konrad Discher (Coun­sel, Real Estate, all Frankfurt).

Gleiss Lutz worked as lead coun­sel with teams in various jurisdictions.

About Gleiss Lutz 

Gleiss Lutz regu­larly advi­ses family-owned compa­nies on large-volume sales tran­sac­tions, inclu­ding the owners of ZKW on the sale of the company to the Korean tech­no­logy group LG for EUR 1.1 billion or the owners of Getrag on the sale to Magna for EUR 1.75 billion.

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de